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Gamma oscillations in V1 are 
correlated with GABAA receptor 
density: A multi-modal MEG  
and Flumazenil-PET study
Jan Kujala1,2, Julien Jung2,3, Sandrine Bouvard4,5, Françoise Lecaignard2,4, Amélie Lothe2, 
Romain Bouet2, Carolina Ciumas2,5, Philippe Ryvlin2,5,6 & Karim Jerbi2,7
High-frequency oscillations in the gamma-band reflect rhythmic synchronization of spike timing in 
active neural networks. The modulation of gamma oscillations is a widely established mechanism in 
a variety of neurobiological processes, yet its neurochemical basis is not fully understood. Modeling, 
in-vitro and in-vivo animal studies suggest that gamma oscillation properties depend on GABAergic 
inhibition. In humans, search for evidence linking total GABA concentration to gamma oscillations 
has led to promising -but also to partly diverging- observations. Here, we provide the first evidence 
of a direct relationship between the density of GABAA receptors and gamma oscillatory gamma 
responses in human primary visual cortex (V1). By combining Flumazenil-PET (to measure resting-
levels of GABAA receptor density) and MEG (to measure visually-induced gamma oscillations), we 
found that GABAA receptor densities correlated positively with the frequency and negatively with 
amplitude of visually-induced gamma oscillations in V1. Our findings demonstrate that gamma-band 
response profiles of primary visual cortex across healthy individuals are shaped by GABAA-receptor-
mediated inhibitory neurotransmission. These results bridge the gap with in-vitro and animal 
studies and may have future clinical implications given that altered GABAergic function, including 
dysregulation of GABAA receptors, has been related to psychiatric disorders including schizophrenia 
and depression.
Neuronal oscillations across multiple frequencies are a prominent feature of brain function. In particu-
lar, high-frequency neural oscillations and broadband activity in the gamma-band (ca. 30–200 Hz) have 
been demonstrated to be involved in a wide range of primary and high-level cognitive processes1–11. 
Interestingly, the blood oxygen level dependent signal (BOLD) used in functional magnetic resonance 
imaging has also been shown to correlate with the gamma-band activity12, across a variety of brain 
regions13,14.
Yet, despite being the subject of a thriving field of research, the neurochemical mechanisms underly-
ing the emergence of gamma-band oscillations in the human brain remain poorly understood. Evidence 
from animal studies suggests that they are generated by a neuronal network containing interconnected 
pyramidal cells and GABA (gamma-aminobutyric acid)-ergic inhibitory interneurons15,16. In line with 
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this, gamma-oscillations measured with Magnetoencephalography (MEG) have been shown to depend 
on GABA concentration levels estimated via magnetic resonance spectroscopy (MRS) in primary 
visual17,18, primary motor19, left dorsolateral prefrontal cortex20. However, MRS-based GABA-Gamma 
correlations are challenged, to a certain extent, by partly inconsistent findings21–23, as well as failure to 
replicate the correlation between GABA-concentration and gamma oscillation frequencies in V124. These 
diverging results could be due to the fact that MRS GABA concentration does not specifically quantify 
synaptic GABA and that it is susceptible to macromolecule contamination24. Other more specific markers 
of GABAergic synaptic signaling might thus be necessary to reliably probe its putative link to gamma 
oscillations.
We hypothesized that GABAA receptor density, which is more closely related to inhibitory neuro-
transmission than total GABA concentration, could provide a more direct assessment of the relation-
ship between GABAergic signaling and gamma oscillations in humans. Recent findings in rodents have 
shown that high-frequency oscillations in the ripple range (80–250) are abolished following focal GABAA 
receptor blockade25. Furthermore, in a mouse model of schizophrenia, the disruption of GABAA receptor 
subunit clustering has been associated with a reduction of gamma power in the ca. 40–70 Hz range26. In 
addition, ample evidence from modeling and in-vitro studies point to the key role of GABAA receptor 
mediated inhibition in the generation of gamma oscillations8,16,27,28. Reliable evidence for such a link in 
humans is still missing.
We set out to evaluate the effects of variations in GABAA receptor distribution, estimated during 
rest, on rhythmic activity recorded during visual perception. To this end, we investigated the relation-
ships between the timing, amplitude and frequency of alpha-, beta- and gamma-band oscillatory activity 
(determined with MEG) and GABAA receptor density (determined with 11C-flumazenil positron emis-
sion tomography, FMZ-PET) in primary visual cortex (V1). We hypothesized that the PET-based GABAA 
receptor measure would form an informative proxy for the strength of inhibition in the V1 neural net-
work, and, thus, predict the properties of visual gamma-band oscillations across individuals. Our results 
demonstrate that the density of GABAA receptors correlates positively with gamma peak frequency and 
negatively with gamma amplitude in human primary visual cortex.
Results
To investigate the relationship between GABAergic inhibition and high-frequency oscillations in V1, we 
measured GABAA receptor density using FMZ-PET and gamma oscillation dynamics with MEG in the 
same population of healthy individuals (n = 13, age 19–29 yrs, mean 24 yrs). The FMZ-PET data used 
to determine the GABAA receptor density were collected while the subjects were resting in the scanner, 
and the characteristics of oscillatory neuromagnetic signals in each individual were estimated from their 
visual responses in a standard n-back working memory task.
Significant modulation of alpha-, beta and gamma-band activity and high density of GABAA 
receptors in V1. Visual stimulation at task onset induced a significant (p < 0.005) prominent 
gamma-band response within a window of 0–600 ms in bilateral occipital and occipito-temporal cortices 
(Fig.  1a). In parallel, both alpha and beta bands showed significant (p < 0.005) suppression of activity 
with respect to baseline (‒200 to 0 ms) in medial occipital cortex (Fig. 1a). No significant modulation of 
activity was detected in the theta-band (4‒7 Hz) at the selected threshold (p < 0.005). The highest density 
of GABAA receptors across the cortex was evident in the bilateral medial occipital cortex (Fig. 1b). The 
observed MEG alpha- and beta-band suppression, the gamma-band increase and the peak of the GABAA 
receptor density in the occipital cortex all fell within or showed spatial overlap with the anatomically 
defined primary visual cortex (Fig. 1c). In addition to the visual regions, there was both modulation of 
gamma-band activity and a high density of receptors in the left cingulate cortex. In the bilateral V1, the 
stimulation induced a prominent gamma-band response at around 100–500 ms and in almost the entire 
evaluated frequency range, peaking at ~300 ms and ~65 Hz (Fig. 1d). The alpha- and beta-band suppres-
sions occurred slightly later, peaking at around 400 ms and 12 Hz (alpha) and at ~350 ms and ~20 Hz 
(beta). The responses showed substantial variability across subjects, particularly for the gamma-band 
peak frequency and timing (Fig. 2).
GABAA receptor density correlates with gamma-band frequency and amplitude in V1. The 
correlation analysis between FMZ-PET data and MEG neural response properties in V1 revealed a sig-
nificantly positive correlation between GABAA receptor density and gamma peak frequency (rho = 0.74, 
p = 0.014; 95% confidence limits for correlation, CI95%, 0.50 − 0.90; Fig.  3a) and a significantly nega-
tive correlation between GABAA receptor density and gamma amplitude (rho = -0.70, p = 0.031; 
CI95% = − 0.86 − 0.45; Fig.  3b). The amplitude and frequency of the gamma-band activity were, how-
ever, not mutually correlated (rho = -0.47, p = 0.17). By contrast to the gamma-band, the alpha- and 
beta-bands did not show significant correlations with GABAA receptor density, neither for peak amplitude 
(alpha, rho = -0.07, p = 0.86; CI95% = − 0.44 - 0.33; beta, rho = -0.02, p = 0.97; CI95% = − 0.50–0.42) 
nor for frequency (alpha, rho = -0.20, p = 0.58; CI95% = − 0.71 − 0.06; beta, rho = 0.51, p = 0.14; 
CI95% = 0.27 − 0.80; Fig. 3). Moreover, no significant correlation between peak timing and GABAA recep-
tor density was detected in any of the frequency bands (alpha, rho = 0.23, p = 0.53; beta, rho = 0.6, 
p = 0.073; gamma, rho = 0.40, p = 0.25).
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Figure 1. Medial views of modulation of neural activity, distribution of GABAA receptors and the 
primary visual cortex (V1). (a) Modulation of neural activity in the alpha-, beta- and gamma-bands with 
respect to baseline time-window (paired t-test, p < 0.005, uncorrected). (b) Cortical GABAA receptor density 
across subjects (threshold at mean + 1 SD). (c) Consistency of V1 in the template brain across subjects. 
(d) Group-level neural responses (normalized units) in the anatomically defined bilateral V1. The data are 
shown for the 10 subjects for whom both MEG and PET data were recorded successfully. Cortical-level 
visualization was performed using FreeSurfer software57.
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Correlation between GABAA receptor density and gamma-band activity is a specific mech-
anism in V1. To assess the robustness and specificity of the correlation observed between GABAA 
receptor density and V1 gamma oscillation properties, we conducted extensive additional analyses 
exploring multiple potential confounds. First, to make sure that the observed correlations were specif-
ically linked to the GABAergic properties of the V1 region, we recomputed the correlations replacing 
V1 receptor density with the overall brain-wide GABAA-density. The results (Fig. 4a) demonstrate that 
the amplitude and frequency properties of V1 gamma-band activity are not correlated with the total 
GABAA-density (amplitude, rho = -0.33, p = 0.35; CI95% = − 0.64 − 0.00; frequency, rho = 0.44, p = 0.21; 
CI95% = 0.13 − 0.71). We also tested whether correlations could arise between the gamma-activity proper-
ties and anatomical properties of V1: No significant correlation was detected between the gamma proper-
ties and volume (amplitude, rho = -0.14, p = 0.71; frequency, rho = 0.57, p = 0.084 CI95% = 0.32 − 0.74) 
or surface area (amplitude, rho = -0.05, p = 0.89; frequency, rho = 0.57, p = 0.084; CI95% = 0.20 − 0.71) 
of V1 (Fig. 4bc). Furthermore, given that previous reports have reported relationships between GABAA 
receptor and neuronal density29 and between gamma frequency and cortical surface area30, we also tested 
whether the observed correlations subsist after regressing out the effect of these parameters. To this end, 
we replicated the main correlation analyses using PET data from which we first regressed out V1 gray 
matter density and surface area. The conducted regression strengthened the correlation measured between 
GABAA receptor density and gamma-band peak frequency (rho = 0.86, p = 0.0013; CI95% = 0.73 − 0.98), 
whereas the correlation between the receptor density and gamma-band amplitude only showed a trend 
(rho = -0.56, p = 0.096; CI95% = − 0.83 − 0.14). The correlations results summarized in Table 1 also show 
that this tendency was further confirmed using a Bayes factor (BF) analysis, which provided evidence 
against the null hypothesis of no correlation with gamma frequency (BF = 6.0064; Pearson’s r = 0.75973, 
Figure 2. Anatomical definition of and the neural responses in V1 for 2 subjects. Anatomically defined 
V1 (top), time-frequency representations (TFR) of the neural responses (middle), and the time-courses of 
modulation of activity in the alpha-, beta, and gamma-bands (bottom). In the TFRs, the black lines show the 
spectral behavior across the 0 to 600 ms time-window. In the lower bands (5–30 Hz), the curves have been 
inverted (prominent deflection indicates strong suppression). Cortical-level visualization was performed 
using FreeSurfer software57.
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p = 0.0108) but no evidence against the null hypothesis when it came to gamma-amplitude (BF = 1.4159, 
Pearson’s r = -0.61411, p = 0.0589).
To further probe the robustness of our findings, we also computed correlations between V1 gamma 
oscillation characteristics (peak frequency and amplitude) and the PET-based GABAA receptor density 
in randomly selected sets of voxels across the brain (either randomly distributed voxels or spatially con-
tiguous random voxel sets). The magnitude of the correlations between the V1 MEG estimates and PET 
GABAA receptor data from any of the 200 random sets of PET-voxels was systematically lower than the 
ones obtained with the corresponding V1-PET values. We also explored whether our findings depend on 
the way the gamma-band modulations were evaluated. By replacing absolute with percent signal change, 
a significant correlation was still present between the GABAA receptor density and the peak gamma 
frequency (rho = 0.84, p = 0.0024; CI95% = 0.68 − 0.97); however, the correlation between GABAA recep-
tor density and peak amplitude was no longer significant (rho = -0.34, p = 0.36; CI95% = − 0.57 − 0.12). 
Finally, we found that neither peak frequency nor amplitude of V1 gamma correlated with the subjects’ 
age (frequency, rho = 0.47, p = 0.17; amplitude, rho = -0.10, p = 0.77).
Discussion
By combining MEG and Flumazenil-PET measurements the current study reveals that the density of 
GABAA receptors correlates positively with gamma peak frequency and negatively with gamma ampli-
tude in primary visual cortex. These results support the view that gamma-range neuronal response pro-
files across individuals are shaped by inhibitory neurotransmission, assessed by GABAA receptor density.
The prominent correlation between GABAA receptors and gamma peak frequency is in-line with 
modeling work31 which predicts that the frequency strongly depends on the balance between AMPA and 
GABA synaptic currents. This may be explained by the fact that both pyramidal-to-interneuron connec-
tions and the pyramidal-to-pyramidal connections tend to decrease population frequency. Our findings 
thus improve our understanding of the neurochemical mechanisms that determine gamma oscillations 
in human cortex. Such insights are critical given the importance of precise spike time correlations across 
networks for synaptic integration and plasticity.
Figure 3. MEG-PET correlation in V1. Correlation between the total GABAA receptor density and the 
modulation peak (a) frequency and (b) amplitude in the gamma-, alpha-, and beta-bands.
www.nature.com/scientificreports/
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Notably, while the significant positive correlation between GABAergic inhibition and peak V1 
gamma frequency agrees with two previous MRS-MEG studies17,18, the significant negative correlation 
we observed between GABAA receptor density and gamma amplitude was not observed in these stud-
ies. Interestingly, previous results have, in fact, shown that the administration of both alcohol32 and 
lorazepam33 may affect both the frequency and amplitude of gamma-band activity in the visual cortex. 
However, it should be noted that in the present study the statistical significance observed in the gamma 
Figure 4. Correlation between V1 gamma-band activity, whole-brain GABAA receptor density and size 
of V1. (a) Correlation between the whole-brain receptor density and the peak frequency and amplitude. (b) 
Correlation between the volume of V1 and the peak frequency and amplitude. (c) Correlation between the 
surface area of V1 and the peak frequency and amplitude.
Correlation Spearman’s rho Pearson’s r Bayes Factor (BF)
Gammafrequency -GABAA 0.74 (p = 0.014) 0.76 (p = 0.011) 6.00
Gammafrequency -GABAA (regressed) 0.86 (p = 0.0013) 0.91, (p = 0.0002) 163.25
Gammaamplitude -GABAA − 0.70 (p = 0.031) − 0.61 (p = 0.056) 1.42
Gammaamplitude -GABAA (regressed) − 0.56 (p = 0.096) − 0.49 (p = 0.15) 0.68
Table 1.  Correlation between GABAA receptor density and gamma-band activity in V1. Overview of 
results and statistical significance of the correlation analyses between GABAA receptor density and gamma 
frequency and amplitude in V1, measured respectively with FMZ-PET and MEG. Four correlations were 
investigated using three distinct correlation measures (Spearman, Pearson and a Bayes factor). The four 
correlations examined (left most column) are the correlations between either gamma frequency or gamma 
amplitude with GABAA receptor density either with (GABAA (regressed)) or without (GABAA) regression step.
www.nature.com/scientificreports/
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amplitude correlation (rho = -0.7, p = 0.031) was weaker than the one we found for gamma frequency 
(rho = 0.74, p = 0.014). Besides, when regressing out the effect of gray matter density and size of V1, we 
observed that the gamma frequency correlation was actually enhanced (rho = 0.86, p = 0.0013), whereas 
the correlation between the receptor density and gamma amplitude only showed a trend to significance 
(rho = -0.56, p = 0.096). Furthermore, the Bayes factor correlation evidence results also confirm the 
statistical significance of the gamma-frequency-GABAA but not the gamma-amplitude- GABAA corre-
lation (Table 1).
Previous reports have also suggested that the frequency of gamma-band activity in the visual cortex 
may depend on the surface area of V1, which, in turn, is linked to the horizontal connectivity and homo-
geneity within the region30. In the present study, correlations between gamma-band peak frequency and 
V1 surface area or volume did not reach significance (p = 0.084, in both cases). There are two possible 
explanations for this difference. First, in the study by Schwarzkopf et al.30, the surface area of V1 was 
defined using retinotopic mapping, whereas in our study the definition was based on a probabilistic 
atlas and the curvature of each subject’s cortex. Second, the definition of the surface area of V1 is only a 
surrogate of the homogeneity of V1, and would thus not necessarily correlate directly with the measured 
oscillation frequency. Interestingly, other studies have also failed to replicate the findings by Schwarzkopf 
et al.30 with respect to the relationship between V1 size and gamma properties34. Furthermore, our cor-
relation analyses between FMZ-PET and alpha or beta oscillations provide no evidence for the influence 
of the GABAergic system on oscillatory amplitude and frequency in V1 at these lower frequencies. Thus, 
our data indicate that in V1 GABAergic inhibition primarily affects the properties of oscillatory neural 
responses in the gamma-band.
Exploring the neurochemical basis of neuronal oscillations, and its putative link to GABAergic inhi-
bition in particular is a challenging endeavor35. A few recent studies were able, using MEG and MRS 
measurements, to link the concentration of GABA to the properties of oscillatory activity in the human 
brain17–20, and, specifically, to the peak frequency of gamma band-activity, in line with predictions from 
computational models of neural populations31. Interestingly, initial reports of correlation between GABA 
concentration and gamma oscillation frequency in human primary visual cortex17 were not replicated 
by a recent study24. The studies differed, among other things, in the number of participants, the type of 
MRS sequence used and the size of the MRS voxel of interest. Yet, irrespective of the reasons behind the 
differing results, the diverging findings between these studies but also from other reports21–23,36 do ques-
tion the reliability of using MRS as a measure of the GABAergic mechanisms thought to mediate gamma 
oscillations24. MRS measurement of GABAergic inhibition suffers from susceptibility to macromolecule 
contamination and the need to sample large voxels. In addition, because MRS measures an overall GABA 
concentration level, it cannot be used to distinguish the contributions of neurotransmitter synaptic pool 
from the metabolic pool37. In fact, the quantification of GABA concentration following selective mod-
ulation with Tiagabine suggests that the MRS signal is only weakly affected by synaptic GABA38. This 
highlights the need to examine in vivo GABAergic inhibition and the GABA-gamma relationship with 
alternative techniques39. To this end, we chose Flumazenil-PET which allows quantification of GABAA 
benzodiazepine receptor density, a measure likely to be more directly related to the GABAergic inhibi-
tory mechanisms involved in gamma oscillations; the correlation we found between gamma-frequency 
and GABAA receptor density in V1 supports the hypothesis that FMZ-PET measurements might indeed 
be better surrogate for GABAergic inhibition than MRS-based estimates. It should be noted, however, 
that although our findings were robust to numerous control analyses, they would certainly benefit from 
replication in a larger cohort. Sample size is a critical limitation in such correlation analyses and may 
potentially explain the discrepancies previously observed in MRS-based studies on the same question17,24.
In a sense, our results are consistent with both the Muthukumaraswamy et al.17 and the Cousijn 
et al.24 studies: The significant GABA-gamma frequency correlation replicates and extends results of the 
former study, and the fact that it has been unraveled using a technique more selective to GABAergic 
inhibition is in line with conclusions of the latter study. Moreover, discrepancies between MRS-based 
GABA-concentration and FMZ-PET-based GABAA receptor density measures are to be expected. It has 
been shown that vigabatrin may change the tissue GABA levels without an associated change in the 
benzodiazepine downregulation40, and TMS-based estimates of synaptic GABAA and GABAB activity do 
not necessarily correlate with the MRS-based concentration measures41–43.
Nevertheless, it is important to note that the claim made here about the potential higher suitability of 
FMZ-PET compared to MRS, only relates to the specific question of linking gamma oscillation properties 
to GABAergic inhibition. MRS-mediated GABA concentration measures provide highly relevant findings 
linking GABA levels to behavior. For instance, GABA concentration in frontal eye fields (FEF) predicts 
saccade distractibility44 whereas its concentration in supplementary motor area (SMA) is correlated with 
responsiveness of subconscious motor mechanisms45. Whether such explorations would benefit in any 
way from measuring GABAA receptor densities is an open question.
Finally, it is noteworthy that although FMZ-PET provides an assessment of GABAA receptor density 
rather than total GABA, neither FMZ-PET nor MRS-derived measures provide a direct quantification 
of inhibition strength. Flumazenil cannot be used to isolate a specific synaptic GABA-benzodiazepine 
receptor signal: The [11C]Flumazenil radioligand binds with similar affinity to synaptic (α 1-α 3) and to 
extrasynaptic (α 5) subunits of GABA-benzodiazepine receptors. In contrast, recent findings indicate that 
the inverse agonist GABA-benzodiazepine receptor PET tracer [11C]Ro15-4513 can be used to quantify 
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specific synaptic (alpha-1 subtype) signals46 and can detect acute increases in synaptic alpha-1 GABA37. 
Combining data from [11C]Ro15-4513 PET with MEG measurements could help fine-tune the relationship 
between GABAergic inhibition and gamma oscillations. Moreover, it should be noted that at present it 
is difficult to associate our findings with the extensive modeling, animal and imaging work that shows 
that increased GABAergic efficacy (as measured by the inhibitory postsynaptic current decay times) leads 
decreased gamma frequencies32,33,47–49. Our results suggest that the PET based GABAA receptor density 
measurement can serve as a proxy for the total inhibition strength that has been suggested to also affect 
the gamma frequency31. It is, however, unclear how the GABAA receptor density links to GABAergic 
efficacy and the various network kinematics properties that have been shown to influence the frequency 
of gamma oscillations8.
In conclusion, the present results show a prominent correlation between PET based measurements 
of GABAA receptor density and MEG based recordings of gamma-band oscillations in primary visual 
cortex. These results provide the first evidence in humans for a direct link between gamma oscillation 
properties and inhibitory neurotransmission indexed by GABAA receptor density. Moreover, our find-
ings also suggest that Flumazenil based PET-GABAA estimates provide a spatially specific measure of 
GABAergic inhibition that, in combination with MEG measurements, could help elucidate the mecha-
nisms that determine the properties of gamma-band oscillations and their variability across individuals 
in health and disease.
Methods
Subjects and experimental design. Thirteen healthy, native French-speaking subjects participated 
in the study. For one subject, the MEG recording failed due to technical reasons, and a second sub-
ject did not participate in the PET recording. In addition, the MEG data of a third subject had to be 
discarded due to excessive blinking. Both PET and MEG data of sufficient quality were thus recorded 
from 10 subjects (1 female, 9 males; age 19–29 years, mean 24 years). Informed consent was obtained 
from all subjects, in agreement with the prior approval of the Institutional Review Board and by the 
National French Science Ethical Committee (CPPRB). All methods were conducted in accordance with 
the CPPRB guidelines. The MEG experiment consisted of a classical working memory task of visually 
presented letters, with 3 s intervals between consecutive letters. Each letter was shown for 300 ms. The 
paradigm comprised three different memory load conditions (1-back, 2-back and 3-back tasks), and the 
subjects indicated with a button press, after each letter, whether the letter matched or did not match the 
appropriate preceding letter. Here, we focus on the initial average visual response across the three tasks 
for the non-target trials; we excluded the target-trials where the subjects’ behavior would have been 
markedly different with respect to the non-target trials. These trials and the early time-window contain 
the neural responses that reflect the perception and encoding of the presented letters to memory. The 
PET data used to determine the GABAA receptor density were collected while the subjects were resting 
eyes-closed in the scanner.
MEG, PET and MRI data collection. All data (MEG, PET and MRI) were collected from the same 
participants at the CERMEP imaging centre (Lyon, France). The MEG data were recorded in a magnet-
ically shielded room using a 275-channel CTF whole-head system. The signals were band-pass filtered 
at 0.016‒150 Hz and sampled at 600 Hz. The PET data were recorded with a Siemens HR + camera, and 
[11C]flumazenil (FMZ), an agent that binds to benzodiazepine (BZD) receptor, was used. FMZ (RO15-
1788) was labeled with 11C, using the methylation process50. A dynamic 3D acquisition was applied 
providing 12 consecutive frames of 63 contiguous 2.42 mm thick slices, with an isotropic spatial resolu-
tion near 5 mm3 FWHM (full width at half-maximum). A 68Ge transmission scan was used to measure 
the attenuation correction. A partial saturation protocol consisting of a single intravenous injection of a 
mixture of 5 mCi of [11C]FMZ and 0.01 mg/kg of unlabeled FMZ was used, followed by acquisition of the 
emission data for 55 minutes. This single injection allowed the calculation of B′ max parametric images, 
i.e., estimates of receptor density, without arterial blood sampling51. Anatomical MRIs were collected 
with a 1.5 Tesla scanner (Siemens Sonata Maestro Class).
MEG data analysis. Neural activity estimates were obtained from the MEG signals with event-related 
Dynamic Imaging of Coherent Sources (erDICS)52, a beamforming technique in the time-frequency 
domain. In erDICS, the cortical-level beamforming estimates are based on the sensor-level time-dependent 
cross-spectral density matrix (CSD), computed using Morlet wavelets53. Here, wavelets of width 7 were 
used to calculate the CSD in the range from 200 ms before stimulus onset to 800 ms post stimulus at 
17 ms intervals; the width parameter defines both the spectral bandwidth and duration of the of the 
wavelets. The estimation of the time-frequency data was conducted by constructing wavelets at dif-
ferent frequency intervals at the different frequency ranges; the range from 4 to 15 Hz was sampled 
with 0.25 Hz resolution, whereas the range from 15 to 30 Hz and 36 to 104 Hz were sampled with 0.5 
and 2 Hz resolutions, respectively. Trials in which the amplitude of either the vertical or the horizontal 
electro-oculogram exceeded 150 μ V were rejected. In addition, the MEG data were examined visually 
and data segments that contained artifacts were excluded from the analysis. The number of accepted 
trials varied between 151–254 across subjects. The beamforming estimates of cortical oscillatory power 
levels at different frequencies were computed, using a spherical head model, at each time-instance, as 
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an average of the time-bin itself and six preceding and following time-bins; the baseline activity level 
per frequency bin was estimated as the average power in the − 200 to 0 ms baseline interval (total of 13 
time-bins as well). For frequencies up to 30 Hz, the estimates were computed for individual frequency 
bins, whereas in the interval of 40–100 Hz, we averaged the data across an 8 Hz window at each bin to 
reduce the effects of noise (e.g., estimate of activity of 40 Hz was calculated based on the average CSD at 
the interval of 36–44 Hz). The general effects of the stimulation were evaluated at the group-level (paired 
t-test, p < 0.005, uncorrected) by comparing the average activity in the alpha (8–13 Hz), beta (15–25 Hz) 
and high-gamma band (60‒90 Hz) between the pre-stimulus (-200 to 0 ms) and the post-stimulus (0 to 
600 ms) time-windows. For visualization, the results were projected to the surface of the brain.
PET data analysis. Static PET images were obtained by summing frames 8–12 from the dynamic 
imaging (corresponding to the acquisition period from 20 to 55 min post-injection). These static images 
of the PET volumes were realigned to the anatomical MRIs. Ten millimeter circular ROIs were placed 
over the midportion of the pons, a suitable reference region for the calculation of the non-specific FMZ 
binding51; the reference encompassed 7–9 consecutive MRI slices displaying that structure. These ROIs 
were then transferred onto the corresponding FMZ-PET slices. An additional circular ROI with 15 mm 
diameter was placed over the occipital cortex which commonly displays a high concentration of BZD 
receptors54. A partial-saturation model, based on a Scatchard plot, was then used to obtain the B′ max 
parametric images55. In this model, the free ligand concentration is estimated in the pons, whereas the 
range of the bound ligand concentration is evaluated in the occipital cortex. Using this approach we 
obtained, for each subject, a set of 63 contiguous 2.42 mm thick parametric images of BZD receptor 
B′ max. Each individual’s PET data were smoothed using a 15 × 15 × 21 mm full width at half maximum 
Gaussian kernel; the level of smoothing was chosen to achieve similar resolution to the MEG estimates 
of neural activity56.
MEG-PET correlation analysis in the primary visual cortex. The MEG estimates were computed 
separately in each voxel of a grid that covered the gray matter surface of the brain. An equivalent spatial 
sampling across subjects was achieved by first forming a volumetric grid with 6-mm sampling in the 
template brain. A grid point was included in the analysis when it was within 1.5 cm of the brain surface. 
The template brain grid, consisting of 3922 points, was transformed, via an elastic transformation (imple-
mented in SPM8; Wellcome Trust Centre for Neuroimaging), to each individual’s anatomy. The MEG 
beamforming estimates were calculated directly at these individual-level grid points. The PET-data were 
coregistered with each individual’s anatomical MRI in SPM8.
The MEG-PET correlation analysis was conducted in the bilateral primary visual cortex (V1). The 
anatomical definition of V1 (see Figs 1c, 2) was based on the automatic segmentation and parcellation 
procedure in Freesurfer 5.357; in the procedure, the bilateral V1 is defined based on a probabilistic atlas 
and subject-specific cortical folding patterns58. Following the segmentation of the gray matter surface 
and the determination of the V1 labels (left/right) in the surface space, the labels were transformed 
into volumetric data and the MR-voxels corresponding to the V1-gray matter surfaces were identified. 
With regard to the MEG data, we determined, for each subject, the grid points that belonged to V1, 
and collected the MEG estimates across these grid points. The amplitudes of each subject’s data were 
normalized by the standard deviation in all V1 grid points across all frequency bins in the baseline 
time-window; the normalized estimates were used to eliminate the effects of head and brain geometry 
on the amplitude estimates. This normalization was conducted separately for the low (4 to 30 Hz) and 
high-frequency (40‒100 Hz) bands. For the PET data, we determined for each V1 MR-voxel the closest 
corresponding PET-voxel, and defined the unique set of these V1-PET voxels. The MEG responses were 
computed by subtracting the average activity during the baseline time-window from the post-stimulus 
time-bins, separately at each frequency; the MEG responses used in the MEG-PET correlation analysis 
were obtained by averaging the MEG responses across the V1 grid points. For each subject, we identified 
the peak frequency, timing and amplitude of the MEG responses, separately for the alpha- (7‒14 Hz), 
beta- (15‒30 Hz), and gamma-bands (40‒100 Hz). The peak frequency was identified as the frequency 
showing the largest modulation between 0 and 600 ms; the peak timing was defined as the time-instance 
between 0 and 600 ms showing the largest modulation of activity in each band (alpha, beta, gamma); 
the peak amplitude was determined at the time-frequency bin corresponding to the peak frequency and 
time-instance. The amplitude measures are reported in arbitrary units as they have been normalized by 
the standard deviation across frequencies and V1 grid-points. As the GABAA estimate we used the total 
GABAA receptor density in the unique set of V1-PET voxels. The correlation between the PET-GABAA 
estimates and the MEG estimates were computed using Spearman’s rho.
We also evaluated the possibility of finding correlations between the V1-specific MEG estimates and 
PET-GABAA estimates in random voxel sets outside the visual cortex (selected from among voxels that 
were more than 4 cm from the primary visual cortex). Here, we selected 100 sets of fully random voxels 
and 100 sets of random contiguous voxels (clusters); for both set-types, an equal number of voxels to 
voxels in each subjects’ V1 were selected. We also investigated whether it would matter if one quan-
tifies the modulations as an absolute or percent signal change between the post-stimulus and base-
line time-windows. In addition to the MEG-PET correlation analysis, we also evaluated the correlation 
between the size of V1 (volume and surface area) and the MEG responses. Moreover, because FMZ-PET 
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based measures of GABAA receptor density have been used as a surrogate marker for neuronal density29, 
it is possible that any observed relationship between GABAA density estimates and rhythmic activity 
could be due to inter-subject differences in neuronal volume of V1. Moreover, previous reports have 
suggested that the gamma-band frequency is dependent on the surface area of V130. To account for the 
contribution of these possible confounding factors, we applied linear regression to remove the effects of 
V1 surface area and gray matter density from the PET based GABA-A estimates and ran the main corre-
lation analyses over again. Note that the gray matter density in V1 was determined by first computing the 
proportion of gray matter for each PET voxel and by averaging these values across V1. Unless mentioned 
otherwise, for all correlations analyses reported here between GABAA receptor density on one hand and 
oscillatory amplitude or frequency on the other, across the population, we used uncorrected p-values.
Finally, in addition to Spearman’s rank correlation analysis, we also computed Pearson’s correlation 
coefficient and a Bayes factor (BF) based on the approach described by Wetzels and Wagenmakers59. BF 
summarizes the ratio of evidence for a correlation of any kind against the evidence for no correlation (the 
null hypothesis). Despite the lack of clear-cut categorical boundaries, a BF < 0.3 is taken as an indication 
in favor of and a BF > 3 as strong evidence against the null hypothesis60.
As with low number of subjects the correlation estimates may be influenced by outliers in the data, we 
computed the 95% confidence limits for the correlation estimates using bootstrapping. In the approach 
we left out data pairs for 2 random subjects 200 times, and computed the correlation and p-values for the 
re-sampled data. From the obtained distribution of 200 correlation-values we calculated the 95% upper 
and lower confidence limits. This procedure was applied to all main correlation analyses.
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